CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- 4 Grant or award President and CEO acquired 11,010 shares (grant or award)
- 4 Grant or award President and CEO acquired 12,042 shares (grant or award)
- 4 Grant or award President and CEO acquired 12,844 shares (grant or award)
- 4 Open-market buy Director bought 1,598 shares at $1.79 ($2,854)
- 4 Grant or award President and CEO acquired 11,820 shares (grant or award)
- 4 Grant or award President and CEO acquired 13,380 shares (grant or award)
- 4 Grant or award President and CEO acquired 13,196 shares (grant or award)
- 4 Grant or award President and CEO acquired 12,272 shares (grant or award)
- 4 Grant or award President and CEO acquired 11,748 shares (grant or award)
- 4 Grant or award President and CEO acquired 10,947 shares (grant or award)
- 4 Grant or award President and CEO acquired 9,585 shares (grant or award)
- 4 Grant or award President and CEO acquired 9,175 shares (grant or award)
- 4 Grant or award President and CEO acquired 10,140 shares (grant or award)
- 4 Shares withheld for taxes President and CEO gave up 75,529 shares (to pay taxes)
- 4 Open-market buy Director bought 1,000 shares at $1.59 ($1,591)
- 4 Open-market buy President and CEO bought 1,000 shares at $1.52 ($1,520)
- 4 Grant or award President and CEO acquired 13,380 shares (grant or award)
- 4 Grant or award President and CEO acquired 143,836 shares (grant or award)
- 4 Grant or award President and CEO acquired 15,086 shares (grant or award)
- 5 Insider Annual Insider Trading Report
Page 7 of 39 · 776 filings